Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Tempest Therapeutics, Inc. (TPST) had Free Cash Flow of $-16.47M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-7.87M |
|
-- |
|
-- |
|
$7.97M |
|
$-7.97M |
|
$0.10M |
|
$-7.87M |
|
$-7.87M |
|
$-7.87M |
|
$-7.87M |
|
$-7.87M |
|
$-7.87M |
|
$-7.97M |
|
$-7.90M |
|
3.80M |
|
3.80M |
|
$-2.07 |
|
$-2.07 |
|
| Balance Sheet Financials | |
$15.10M |
|
$0.75M |
|
$9.38M |
|
$24.48M |
|
$7.14M |
|
-- |
|
$7.56M |
|
$14.70M |
|
$9.78M |
|
$9.78M |
|
$9.78M |
|
4.44M |
|
| Cash Flow Statement Financials | |
$-16.47M |
|
-- |
|
$0.48M |
|
$30.71M |
|
$14.72M |
|
$-15.99M |
|
$2.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-16.47M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-80.45% |
|
-80.45% |
|
-32.14% |
|
-80.45% |
|
$2.20 |
|
$-4.33 |
|
$-4.33 |
|